About this Journal Submit a Manuscript Table of Contents
Enzyme Research
Volume 2012 (2012), Article ID 416062, 7 pages
http://dx.doi.org/10.1155/2012/416062
Research Article

Inhibition of Heme Peroxidases by Melamine

Division of Biochemical Toxicology, National Center for Toxicological Research, US Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079, USA

Received 23 March 2012; Revised 23 May 2012; Accepted 5 June 2012

Academic Editor: Fabrizio Briganti

Copyright © 2012 Pattaraporn Vanachayangkul and William H. Tolleson. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

In 2008 melamine-contaminated infant formula and dairy products in China led to over 50,000 hospitalizations of children due to renal injuries. In North America during 2007 and in Asia during 2004, melamine-contaminated pet food products resulted in numerous pet deaths due to renal failure. Animal studies have confirmed the potent renal toxicity of melamine combined with cyanuric acid. We showed previously that the solubility of melamine cyanurate is low at physiologic pH and ionic strength, provoking us to speculate how toxic levels of these compounds could be transported through the circulation without crystallizing until passing into the renal filtrate. We hypothesized that melamine might be sequestered by heme proteins, which could interfere with heme enzyme activity. Four heme peroxidase enzymes were selected for study: horseradish peroxidase (HRP), lactoperoxidase (LPO), and cyclooxygenase-1 and -2 (COX-1 and -2). Melamine exhibited noncompetitive inhibition of HRP , and LPO showed a mixed model of inhibition . The inhibition of HRP and LPO was confirmed using a chemiluminescent peroxidase assay. Melamine also exhibited COX-1 inhibition, but inhibition of COX-2 was not detected. Thus, our results demonstrate that melamine inhibits the activity of three heme peroxidases.

1. Introduction

In 2007, the incidence of nephrotoxic renal failure of cats and dogs caused the recall of 1,177 lots of pet food products in the USA that were contaminated with melamine, cyanuric acid, and related triazine compounds [1]. The US Food and Drug Administration (FDA) and the US Department of Agriculture identified triazine contaminants in wheat gluten, rice protein, and corn gluten raw materials imported from China that were used as ingredients in pet food products [2]. In 2008, over 50,000 children exposed to foods manufactured using melamine-contaminated milk powder were hospitalized with renal injuries, and at least 6 died [35].

Melamine is a high-production industrial chemical used in the manufacture of thermosetting plastics, flame retardants, and fertilizers [6]. Melamine is an organic base with a 1,3,5-triazine skeleton (Figure 1) and a high nitrogen content (66% w/w). Ingredients used in food manufacturing that have higher total nitrogen levels achieve proportionally higher market prices because the total nitrogen level is used as an indirect index of the protein content. It has been alleged that melamine was added intentionally to raw materials sold by distributors to food manufacturers to elevate the apparent nitrogen content of those ingredients.

416062.fig.001
Figure 1: Structure of melamine (2,4,6-triamino-1,3,5-triazine [108-78-1)].

The toxicity of melamine has not been studied in humans; however, several studies have demonstrated renal crystal formation and kidney failure in rats, fish, cats, pigs, and monkeys following administration of melamine and cyanuric acid [713]. The solubility of melamine cyanurate is lower at physiological pH and ionic strength than it is in the acidic gastric compartment [14], provoking us to speculate how these two compounds could be absorbed and distributed throughout the body without crystallizing until passing into the renal filtrate. Wang et al. [15] developed a sensitive chemiluminescent method for detecting melamine in milk that measures the intensities of chemiluminescent emissions released in reactions between myoglobin and luminol. These authors showed that the chemiluminescent intensities of these reactions were diminished in proportion to the concentration of melamine. In support of their model, they also reported that the heme-dependent absorption maximum of myoglobin at 409 nm was decreased in the presence of melamine. Both of these observations are consistent with the formation of a myoglobin-melamine complex. We hypothesized that melamine might be partially sequestered by heme proteins in vivo, limiting the formation of insoluble complexes with cyanuric acid. We also speculated that melamine could interfere with the activity of some heme enzymes. In the current study, we tested this hypothesis by evaluating the effects of melamine on the catalytic activities of four heme peroxidase enzymes: horseradish peroxidase, lactoperoxidase, cylooxygenase-1, and cyclooxygenase-2.

2. Materials and Methods

2.1. Chemicals

Peroxidase type VI-A from horseradish (HRP), lactoperoxidase (LPO), sheep cyclooxygenase-1 (COX-1), human cyclooxygenase-2 (COX-2), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS), potassium iodide (KI), sodium phosphate monobasic monohydrate (NaH2PO4), Bis-Tris (2,2-bis(hydroxymethyl)-2,2′,2′′-nitrilotriethanol), Trizma hydrochloride (tris(hydroxymethyl)aminomethane hydrochloride), 30% hydrogen peroxide (H2O2), bovine serum albumin (BSA), bovine hemin, , , , -tetramethyl-p-phenylenediamine (TMPD), Tween 20, cyanuric acid, and melamine were purchased from Sigma-Aldrich (St. Louis, MO, USA). Sodium arachidonate was purchased from Nu-Chek-Prep (Elysian, MN, USA). Phosphate buffered saline (PBS) was purchased from Fisher Scientific (Houston, TX, USA).

2.2. Instrument

A Synergy 4 Multi-Detection Microplate Reader with the dual-reagent dispense module from Biotek Instrument, Inc. (Winooski, VT, USA) was used for the enzyme activity assays described below.

2.3. Horseradish Peroxidase Assays

The experimental procedure was modified from a spectrophotometric assay for peroxidases (EC 1.11.1.7) [16, 17] that utilizes the reaction mechanism given in Figure 2(a). 50 mM of NaH2PO4, pH 5.0 was used to prepare 7 concentrations of ABTS (1.53, 3.05, 6.1, 9.2, 12.2, 15.25, and 18.4 mM). HRP was diluted with 0.025% BSA and 0.5% Tween 20 in 50 mM NaH2PO4, pH 6.0 to obtain 0.5 unit/mL HRP. 20 mM of melamine was dissolved in PBS as a stock solution and used to prepare 4 concentrations of melamine (5, 10, 15, and 20 mM). 30% H2O2 was diluted with water to obtain 0.3% H2O2.

416062.fig.002
Figure 2: The enzymatic reactions of (a) horseradish peroxidase, (b) lactoperoxidase, and (c) cylooxygenases.

205 μL of ABTS solution, 25 μL of melamine, and 10 μL of 0.5 unit/mL of HRP were added to each well of 96-well UV plate, mixed, and the UV absorption at 405 nm was monitored until constant. The enzyme-catalyzed reaction was started by adding 10 μL of 0.3% H2O2 and the change in absorbance at 405 nm (oxidized ABTS as a product, ε = 36.8 mM−1 cm−1) was recorded for 60 sec. Blank reactions included 10 μL enzyme dilution buffer instead of 0.5 unit/mL HRP.

Final concentrations for the 250 μL reactions were 43 mM NaH2PO4, 0.012% H2O2, 1.25–15 mM ABTS, 0.1–2 mM melamine, and 0.02 unit/mL HRP. Negative control reactions contained cyanuric acid instead of melamine. All reactions were performed at room temperature.

2.4. Lactoperoxidase Assays

The spectrophotometric assay method (see Figure 2 for reaction) developed by Kussendrager and van Hooijdonk [18] was adapted for 96-well microplates. The concentration of LPO was determined by UV absorption at 412 nm (ε = 112.3 mM−1 cm−1). 100 mM Bis-Tris pH 6.0 was used to prepare 7 concentrations of KI (5, 10, 25, 50, 75, 100, and 200 mM), 15 mM H2O2 and 20 mM melamine as a stock solution. Melamine stock solution was diluted to 3 concentrations (8, 12, and 20 mM). LPO was diluted to obtain 30 nM in 0.025% BSA in 100 mM Bis-Tris buffer pH 6.0.

150 μL of melamine (replaced by 150 μL of 100 mM Bis-Tris buffer pH 6.0 for blank reactions) and 20 μL of KI were added to each well. 20 μL of 30 nM LPO and 10 μL of 15 mM H2O2, respectively, were dispensed using automated injectors, reactions were mixed for 1 sec, and the change in UV absorbance at 350 nm due to hypoiodite (HOI) formed as a product (ε = 60 M−1 cm−1) was recorded for the initial 20 sec period at room temperature [19, 20]. Each 200 μL reaction contained 100 mM Bis-Tris buffer pH 6.0, 0.75 mM H2O2, 30 nM LPO, 9–15 mM melamine, and 0.5–20 mM KI. Cyanuric acid replaced melamine in negative control reactions.

2.5. Chemiluminescent Assays for Horseradish Peroxidase and Lactoperoxidase

The chemiluminescent peroxidase substrate for ELISA kits was purchased from Sigma-Aldrich (product code CPS2-60). The procedure given in the technical bulletin was followed as given. All reactions were incubated at room temperature. Solutions containing 2 unit/mL lactoperoxidase and 8 unit/mL horseradish peroxidase were prepared in 0.075% BSA in 50 mM NaH2PO4, pH 6.0. Melamine was dissolved in PBS to provide a 20 mM stock solution used to prepare 9 dilutions of melamine in PBS (1.2–25 mM). 90 μL of melamine and 10 μL of enzyme were added to each well of 96-well microplate (white bottom plate) in triplicate. Then, 100 μL of substrate was added to each well, the microplates were incubated in the dark for 5 min after 5 seconds shaking, and the steady-state chemiluminescent intensity was measured for each well. The total volume was 200 μL per well, and final concentrations were 0.5625–11.25 mM melamine and 0.1 unit/mL LPO or 0.4 unit/mL HRP. Using this system, the intensities of the steady-state chemiluminescent emissions from these reactions are proportional to the rates of the enzyme-catalyzed reactions occurring in these samples.

2.6. Cyclooxygenase Assays

A fluorescence-based COX activity assay kit (Cayman Chemical Company, Ann Arbor, MI, USA) was used in this study following the procedure given by the manufacturer. In this method, the peroxidase activity of COX catalyzes the oxidation and N-deacetylation of ADHP to form resorufin, a highly fluorescent product.

A COX-1 working solution was prepared by diluting the enzyme to 400 unit/mL of COX-1 using the assay buffer provided with the kit (100 mM Tris-HCl, pH 8.0). Similarly, COX-2 was diluted to 20, 100, and 200 unit/mL with assay buffer. A heme cofactor working solution was prepared by diluting 40 μL of the reagent provided in the assay kit with 960 μL assay buffer. Immediately prior to conducting an experiment, the contents of an ADHP substrate vial provided with the kit were dissolved with 100 μL DMSO then diluted with 900 μL assay buffer. A 2.0 mM arachidonic acid substrate solution was also prepared fresh immediately before use according to the manufacturer’s instructions using the supplied reagent, potassium hydroxide, and assay buffer. A 20 mM melamine stock solution was prepared in PBS and diluted to 0.5–20 mM.

Sample wells contained 150 μL of assay buffer, 10 μL of heme, 10 μL of fluorometric substrate (ADPH), 10 μL of COX, and 10 μL of melamine. 10 μL PBS was substituted for melamine in positive control wells. 20 μL assay buffer replaced 10 μL COX, and 10 μL arachidonic acid in background wells. Reactions were initiated by adding 10 μL of arachidonic acid substrate solution to each of the sample and positive control wells rapidly, incubating 60 seconds, then recording the fluorescent intensities for each well (EX 535/EM 590). The final concentrations in each sample well were 0.025–1 mM melamine, 1 unit/mL COX-1 or 1, 5, and 10 unit/mL COX-2, and 0.1 mM arachidonic acid. The fluorescence intensities from background wells were subtracted from those for sample and positive control wells to obtain corrected fluorescence values. Resorufin concentrations in sample and control wells were determined by comparison to standard curves that were prepared in each 96-well assay plate using 8 concentrations of resorufin (0, 0.1, 0.2, 0.4, 0.8, 1.2, 1.6, and 2.0 μM) diluted with assay buffer. Reaction velocities were calculated by dividing resorufin concentrations by the incubation time (1 minute).

2.7. Data Analysis

All experiments were prepared in triplicate and enzyme kinetic parameters were obtained from GraphPad Prism version 5.01 software (GraphPad Software Inc. San Diego, CA, USA). Comparisons using two-tailed ANOVA were considered significant at . Dunnett’s multiple comparisons test was applied to compare treated samples to controls.

3. Results and Discussion

Melamine exhibited noncompetitive inhibition of horseradish peroxidase using the H2O2/ABTS assay, with μM/min,  mM, and  mM (Figure 3 and Table 1). A noncompetitive mechanism of inhibition implies that melamine binding does not compete with ABTS substrate binding but decreases the rate of catalytic turnover. No evidence of inhibition was observed in reactions in which cyanuric acid (1,3,5-triazine-2,4,6-triol) was substituted for melamine (data not shown). Melamine exhibited a mixed-model inhibition of lactoperoxidase (primarily competitive) using the H2O2/KI iodoperoxidase assay (Figure 4 and Table 1) with  mM/sec,  mM, and  mM. A mixed model of inhibition implies that melamine interferes with ABTS binding and also impairs the reaction velocity. Inhibition of horseradish peroxidase and lactoperoxidase by melamine was confirmed using the chemiluminescent peroxidase assay method (Figure 5). Linear trends between luminescent intensity and melamine concentration were evident for both enzymes. Cyanuric acid failed to inhibit horseradish peroxidase and lactoperoxidase using the chemiluminescent assay (data not shown). Unfortunately, enzyme kinetic constants and inhibition constants could not be calculated using this method because the supplier declined to provide the identity and concentration of the chemiluminescent substrate.

tab1
Table 1: Enzyme kinetic parameters for horseradish peroxidase and lactoperoxidase.
fig3
Figure 3: (a) Plots of velocity (V) of oxidized ABTS formation versus ABTS concentration (ABTS) with melamine concentration ranged from 0.5–2 mM. (b) Lineweaver-Burk plots of velocity (V) of oxidized ABTS formation versus ABTS concentration (ABTS) with melamine concentration ranged from 0.5–2 mM showing noncompetitive inhibition.
fig4
Figure 4: (a) Michaelis-Menton plots of the velocity of the lactoperoxidase-catalyzed reaction versus KI concentration with 6–15 mM melamine. (b) Lineweaver-Burk plots showing mixed model inhibition (primarily competitive) of lactoperoxidase by melamine.
fig5
Figure 5: Plots of chemiluminescent intensity for reactions catalyzed by (a) horseradish peroxidase or (b) lactoperoxidase showing inhibition by melamine. Dotted lines depict 95% confidential bands for linear trends.

COX-1 and COX-2 are prostaglandin H synthases (EC 1.14.99.1) that convert arachidonic acid (AA) to prostaglandin H2 (PGH2) in two steps [21]. In the first step, the cyclooxygenase activity of COX acts as a dioxygenase to catalyze the incorporation of two moles of molecular oxygen to arachidonic acid (AA) to form prostaglandin G2 (PGG2), a reactive 15-hydroperoxy-9,10-endoperoxide. COX acts as a peroxidase in the second step in which a cosubstrate molecule serves as an electron donor to reduce the PGG2 hydroperoxyl group which then becomes the hydroxyl group of prostaglandin H2. We evaluated the effects of melamine on the peroxidase activity of COX-1 and COX-2 using 10-acetyl-3,7-dihydroxyphenoxazine (ADHP; Amplex Red) as the electron donor substrate. Melamine exhibited a significant concentration-dependent trend for COX-1 inhibition using the fluorescent assay method (Figure 6(a)). These data showed that COX-1 activity was inhibited in reactions containing 0.05–1.00 mM melamine. Inhibition of COX-2 was not apparent using this method.

fig6
Figure 6: Effects of melamine on peroxidase activity of (a) COX-1 and (b) COX-2.

Recent pharmacokinetic studies showed that melamine administered orally to Sprague-Dawley rats was absorbed almost completely (98.1% bioavailability) and then excreted rapidly ( 194 ± 38 min), primarily via filtration through the kidneys [9]. However, repeated exposure of lambs to high doses of melamine (2, 10, 30, or 100 mg/kg) or to 100 mg/kg melamine plus 100 mg/kg cyanuric acid for 60 days led to increasing melamine levels in the serum (167–267 μg/kg max), liver (158–412 μg/kg max), longissimus dorsi and gluteal muscles (227–374 μg/kg max), and kidney (347–808 μg/kg max) [22]. The tissue levels of melamine observed in animals do not reach levels required for lactoperoxidase or COX-1 inhibition under the conditions described in his report, although it could be speculated that somewhat higher melamine levels might occur within the microenvironment of renal tubule cells. Nonetheless, our results show that melamine interferes with the catalytic activity of three of the four heme enzymes tested, demonstrating intermolecular interactions between melamine and HRP, LPO, and COX-1. Studies by Wang [15] implicated interactions between melamine and another heme protein, myoglobin. Therefore, it will be important to determine whether other proteins present in plasma and/or urine may sequester melamine and/or cyanuric acid. Melamine- or cyanuric binding-proteins may inhibit crystal formation outside of the urinary tract and could influence the adsorption, transport, and retention of these compounds.

Abbreviations

ABTS:2,2′-Azino-bis(3-ethylbenzthiazoline-6-sulfonic  acid)
KI: Potassium iodide
HOI: Hypoiodite
AA: Arachidonic acid
PGG2:Prostaglandin G2
PGH2:Prostaglandin H2
ADHP: 10-Acetyl-3, 7-dihydroxyphenoxazine
TMPD: , , , -Tetramethyl-p-phenylenediamine.

Acknowledgments

The content of this paper does not necessarily reflect the views and policies of the US Food and Drug Administration, nor does mention of trade names or commercial products constitute endorsement or recommendation for use.

References

  1. Melamine Contaminated Pet Foods—2007 Recall List, US FDA, 2008.
  2. J. Y. Yhee, C. A. Brown, C. H. Yu, J. H. Kim, R. Poppenga, and J. H. Sur, “Brief communication: retrospective study of melamine/cyanuric acid-induced renal failure in dogs in Korea between 2003 and 2004,” Veterinary Pathology, vol. 46, no. 2, pp. 348–354, 2009. View at Scopus
  3. C. A. Brown, K. S. Jeong, R. H. Poppenga et al., “Outbreaks of renal failure associated with melamine and cyanuric acid in dogs and cats in 2004 and 2007,” Journal of Veterinary Diagnostic Investigation, vol. 19, no. 5, pp. 525–531, 2007. View at Scopus
  4. C. B. Langman, “Melamine, powdered milk, and nephrolithiasis in Chinese infants,” The New England Journal of Medicine, vol. 360, no. 11, pp. 1139–1141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Bhalla, P. C. Grimm, G. M. Chertow, and A. C. Pao, “Melamine nephrotoxicity: an emerging epidemic in an era of globalization,” Kidney International, vol. 75, no. 8, pp. 774–779, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. K. C. Hau, T. H. Kwan, and P. K. T. Li, “Melamine toxicity and the kidney,” Journal of the American Society of Nephrology, vol. 20, no. 2, pp. 245–250, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Reimschuessel, E. R. Evans, C. B. Stine et al., “Renal crystal formation after combined or sequential oral administration of melamine and cyanuric acid,” Food and Chemical Toxicology, vol. 48, no. 10, pp. 2898–2906, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Liu, S. Li, J. Jia et al., “Pharmacokinetic study of melamine in rhesus monkey after a single oral administration of a tolerable daily intake dose,” Regulatory Toxicology and Pharmacology, vol. 56, no. 2, pp. 193–196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. T. Wu, C. M. Huang, C. C. Lin et al., “Oral bioavailability, urinary excretion and organ distribution of melamine in sprague-dawley rats by high-performance liquid chromatography with tandem mass spectrometry,” Journal of Agricultural and Food Chemistry, vol. 58, no. 1, pp. 108–111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. C. Jacob, R. Reimschuessel, L. S. von Tungeln et al., “Dose-response assessment of nephrotoxicity from a 7-day combined exposure to melamine and cyanuric acid in F344 rats,” Toxicological Sciences, vol. 119, no. 2, pp. 391–397, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Nilubol, T. Pattanaseth, K. Boonsri, N. Pirarat, and N. Leepipatpiboon, “Melamine- and cyanuric acid-associated renal failure in pigs in Thailand,” Veterinary Pathology, vol. 46, no. 6, pp. 1156–1159, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Puschner, R. H. Poppenga, L. J. Lowenstine, M. S. Filigenzi, and P. A. Pesavento, “Assessment of melamine and cyanuric acid toxicity in cats,” Journal of Veterinary Diagnostic Investigation, vol. 19, no. 6, pp. 616–624, 2007. View at Scopus
  13. R. Reimschuessel, C. M. Gieseker, R. A. Miller et al., “Evaluation of the renal effects of experimental feeding of melamine and cyanuric acid to fish and pigs,” American Journal of Veterinary Research, vol. 69, no. 9, pp. 1217–1228, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. W. H. Tolleson, “Renal toxicity of pet foods contaminated with melamine and related compounds,” in Intentional and Unintentional Contaminants in Food and Feed, pp. 57–77, American Chemical Society, Washington, DC, USA, 2009.
  15. Z. Wang, D. Chen, X. Gao, and Z. Song, “Subpicogram determination of melamine in milk products using a luminol-myoglobin chemiluminescence system,” Journal of Agricultural and Food Chemistry, vol. 57, no. 9, pp. 3464–3469, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Keesey, Biochemica Information, Boehringer Mannheim, Indianapolis, Ind, USA, 1st edition, 1987.
  17. J. S. Shindler, R. E. Childs, and W. G. Bardsley, “Peroxidase from human cervical mucus—isolation and characterisation,” European Journal of Biochemistry, vol. 65, no. 2, pp. 325–331, 1976. View at Publisher · View at Google Scholar
  18. K. D. Kussendrager and A. C. M. van Hooijdonk, “Lactoperoxidase: physico-chemical properties, occurrence, mechanism of action and applications,” British Journal of Nutrition, vol. 84, supplement 1, pp. S19–S25, 2000. View at Scopus
  19. J. Paquette and B. L. Ford, “Iodine chemistry in the +1 oxidation-state. 1. The electronic-spectra of OI-, HOI, and H2OI,” Canadian Journal of Chemistry-Revue Canadienne de Chimie, vol. 63, no. 9, pp. 2444–2448, 1985. View at Publisher · View at Google Scholar
  20. J. C. Wren, J. Paquette, S. Sunder, and B. L. Ford, “Iodine chemistry in the +1 oxidation-state. 2. A raman and UV-visible spectroscopic study of the disproportionation of hypoiodite in basic solutions,” Canadian Journal of Chemistry-Revue Canadienne de Chimie, vol. 64, no. 12, pp. 2284–2296, 1986. View at Publisher · View at Google Scholar
  21. A. L. Tsai and R. J. Kulmacz, “Prostaglandin H synthase: resolved and unresolved mechanistic issues,” Archives of Biochemistry and Biophysics, vol. 493, no. 1, pp. 103–124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Lv, J. Wang, L. Wu, J. Qiu, J. Li, Z. Wu, et al., “Tissue deposition and residue depletion in lambs exposed to melamine and cyanuric acid-contaminated diets,” Journal of Agricultural and Food Chemistry, vol. 58, no. 2, pp. 943–948, 2010. View at Publisher · View at Google Scholar · View at Scopus